Developing a scalable process for proprietary enzyme production
Taking Oxford Biotrans’ technology from innovation to commercialisation
UK based SME Oxford Biotrans utilised CPI’s expertise as it progressed its technology from innovation to commercialisation.
Oxford Biotrans is a University of Oxford spin out company, supported by over 20 years of scientific expertise and research. The company is working to develop and commercialise enzymatic process technologies that yield high value chemical compounds.
Oxford Biotrans worked with CPI to develop a scalable process for production of its proprietary enzyme.
An input is a unique capability, service or method of support that was provided, such as equipment or expertise.
- Technical knowledge and expertise
- Process validation
An output is the result of the work, such as an experimental finding, an actual product or a pilot demonstrator.
- Development milestone achieved
- New fermentation process developed
- Economic business case refined
An outcome arises from implementing the outputs, for example, a profit, an investment, providing jobs or delivering societal benefits. Outcomes continue once an innovation has been implemented and deliver benefit every year.
- New product to market
- £4.6m private sector investment secured
- Jobs created and safeguarded